NCT02386709View on ClinicalTrials.gov

Study Evaluating the Utility of 18F-FDG PET in Assessing Early Response to Neoadjuvant Chemotherapy in Patients With Mammary Gland Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

275

Participants

Timeline

Start Date

March 25, 2015

Primary Completion Date

March 25, 2028

Study Completion Date

March 25, 2028

Conditions
FDG PET
Interventions
DEVICE

FDG PET

FDG PET1 before neoadjuvant chemotherapy FDG PET2 after one cycle of neoadjuvant chemotherapy

Trial Locations (1)

21000

Emilie REDERSTORFF, Dijon

All Listed Sponsors
lead

Centre Georges Francois Leclerc

OTHER

NCT02386709 - Study Evaluating the Utility of 18F-FDG PET in Assessing Early Response to Neoadjuvant Chemotherapy in Patients With Mammary Gland Cancer | Biotech Hunter | Biotech Hunter